297
Participants
Start Date
February 16, 2016
Primary Completion Date
November 15, 2019
Study Completion Date
February 14, 2020
SPN-810 (18 mg)
Subjects were randomized to receive SPN-810 9 mg twice each day with food, in addition to the stable dose of the optimized ADHD medication determined from the lead-in period. If initiating treatment before noon, patients should start with the morning dose; if afternoon, the evening dose.
SPN-810 (36 mg)
Subjects were randomized to receive SPN-810 18 mg twice each day with food, in addition to the stable dose of the optimized ADHD medication determined from the lead-in period. If initiating treatment before noon, patients should start with the morning dose; if afternoon, the evening dose.
Placebo
Subjects were randomized to receive Placebo twice each day with food, in the morning and in the evening, in addition to the stable dose of the optimized ADHD medication determined from the lead-in period. If initiating treatment before noon, patients should start with the morning dose; if afternoon, the evening dose.
Icahn School of Medicine at Mount Sinai, New York
Children's National Medical Center/Children's Research Institute, Washington D.C.
iResearch Atlanta, Decatur
Atlanta Center for Medical Research, Atlanta
APG Research, LLC, Orlando
Indago Research & Health Center, Inc., Hialeah
Miami Research Associates, South Miami
Innovative Clinical Research, Inc, Lauderhill
University of South Florida- Dept. of Psychiatry and Neurosciences, Tampa
Gulfcoast Clinical Research Center, Fort Myers
Pedia Research, Owensboro
University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, Cincinnati
Pedia Research, Evansville
AMR Conventions Research, Naperville
St. Charles Psychiatric Associates Midwest Research Center, Saint Charles
Quality Clinical Research, Omaha
Alivation Research, LLC, Lincoln
Laszlo J. Mate, M.D., P.A., North Palm Beach
Louisiana State University Health Sciences Center, Shreveport
Woodland International Research Group, Little Rock
InSite Clinical Research, DeSoto
BioBehavioral Research of Austin P.C., Austin
MCB Clinical Research Centers, LLC, Colorado Springs
Advanced Clinical Research, Meridian
Ericksen Research & Development, Clinton
Metropolitan Neuro Behavioral Institute, Chandler
Alliance for Wellness dba Alliance for Research, Long Beach
ASCLEPES Research Center, Panorama City
Sun Valley Research Center, Imperial
Pacific Institute of Medical Sciences, Bothell
Hassmann Research Institute, Berlin
Houston Clinical Trials, Houston
Supernus Pharmaceuticals, Inc.
INDUSTRY